Darren leads the group’s work on continuous flow chemistry, reactor design, and process development for active pharmaceutical ingredients. His research connects synthetic methodology, reactor engineering, and computational drug discovery, with a sustained focus on demonstrating that flow chemistry can be safer, greener, and more scalable than the batch processes it replaces.